Sign up for Table of Contents Alerts.
Email this page
Print this page
Report
Loss of p27 Expression Through RAS->BRAF->MAP Kinase-Dependent Pathway in Human Thyroid Carcinomas
Maria Letizia Motti, Carmela De Marco, Daniela Califano, Silvia De Gisi, Donatella Malanga, Giancarlo Troncone, Angela Persico, Simona Losito, Fernanda Fabiani, Massimo Santoro, Alfredo Fusco and Giuseppe Viglietto
volume 6 | issue 22
15 November 2007Pages: 2817 - 2825
Subscribe to this journal for $129/year
In the present study, we report that the RAS->BRAF->MAP kinase cascade plays a crucial role in the regulation of the Skp2/p27 pathway in thyroid cancer cells and that this is critical for cell proliferation. In vitro studies with cellular models of human thyroid carcinoma cells demonstrated that the adoptive expression of oncogenic RET/PTC1, Ha-RASV12 or BRAFV600E enhances Skp2 and reduces p27 protein expression in a MAP kinase-dependent manner; that RAS->BRAF->MAP kinasedependent control of p27 expression in thyroid cancer cells occurs by regulating the stability of Skp2 and p27 protein; and that antisense oligonucleotides to p27 suppress growth arrest induced by MEK inhibitors. Finally, analysis of human thyroid carcinomas indicated that MAP kinase-positive thyroid tumoursas detected by immunostaining for p-ERKpresented high p27 degradative activity and low levels of p27 protein (N=30; P<0.05). In summary, our results indicate that constitutive signalling of the MAP kinase cascade contributes to the development of thyroid cancer promoted by activated RAS and BRAF oncogenes and that this occurs, at least in part, by compromising the inhibitory function of p27.
Authors
Maria Letizia Motti
Università Parthenope; Napoli, Italy
Carmela De Marco
Università Federico II; Napoli, Italy
Daniela Califano
Università Federico II; Napoli, Italy
Silvia De Gisi
Università Magna Graecia; Catanzaro, Italy
Donatella Malanga
Università Magna Graecia; Catanzaro, Italy
Giancarlo Troncone
Università Federico II; Napoli, Italy
Angela Persico
Istituto Nazionale Tumori; Napoli, Italy
Simona Losito
Istituto Nazionale Tumori; Napoli, Italy
Fernanda Fabiani
Università Magna Graecia; Catanzaro, Italy
Massimo Santoro
Università Federico II; Napoli, Italy
Alfredo Fusco
Università Federico II; Napoli, Italy
Giuseppe Viglietto
Università Magna Graecia; Catanzaro, Italy




